510(k) Report

510(k) · Cleared

Recalled · 2004

Roche Online TDM Phenytoin

K030428510(k) TraditionalCleared Apr 28, 200377-day reviewClass II21 CFR 862.3350Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · DIP Enzyme Immunoassay, Diphenylhydantoin

Cleared on Apr 28, 2003 as substantially equivalent to K963840 (Boehringer Mannheim Corp., 1996) after a 77-day review. Its family tree reaches back 2 generations to 1991. It has been recalled 2 times.

Decided
Apr 28, 2003
Review
77 days
Class
Class II
Product code
DIP
Recalls
2
Predicates
1

Its longest line of descent runs back 2 generations to K905689 (1991). No later device cites it as a predicate yet.

K905689 · Cedia Phenytoin Assay · Microgenics Corp. · 1991K963840 · Cedia Phenytoin II Assay · Boehringer Mannheim Corp. · 19961990199520002005
  1. Root · 2 generations backK905689 Cedia Phenytoin AssayMicrogenics Corp. · 1991
  2. 1 generation backK963840 Cedia Phenytoin II AssayBoehringer Mannheim Corp. · 1996
  3. This deviceK030428 Roche Online TDM PhenytoinRoche Diagnostics Corp. · 2003
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K905689Cedia Phenytoin AssayMicrogenics Corp.1991—
−1K963840Cedia Phenytoin II AssayBoehringer Mannheim Corp.1996—
0 (this device)K030428Roche Online TDM PhenytoinRoche Diagnostics Corp.2003—
FIG. 1 — Lineage of K030428, 1991–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DIP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K963840Cedia Phenytoin II Assay
Summary page 1
…~~~ 2) Device name Roche ONLINE Phenytoin 3) Predicate We claim substantial equivalence to the Roche CEDIA Phenytoin I1 Assay device [K963840]. 4) Device The Roche ONLINE Phenytoin assay contains an in vitro diagnostic reagent Description system indicated f…
Boehringer Mannheim Corp.1996—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 18, 2004Not classifiedZ-1062-04OtherMay report falsely decreased patient results.
Jun 18, 2004Not classifiedZ-1063-04OtherMay report falsely decreased patient results.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 6.4 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All DIP devices

DIP Enzyme Immunoassay, Diphenylhydantoin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DIP

1in 2008

2007: 12008: 1
2007high 1 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DIP

Too few DIP 510(k)s in any year since 2007 to give a median.

Recalls per year · DIP

1in 2017

2008: 12013: 32014: 22017: 1
2007high 3 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DIP

2in 2025

2007: 22008: 202009: 102010: 592011: 1042012: 512013: 1632014: 572015: 652016: 692017: 552018: 792019: 252020: 172021: 492022: 182023: 422024: 52025: 2
2007high 163 (2013) · low 2 (2007)2025

MAUDE reports naming product code DIP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—02
20081—120
20090—010
20100—059
20110—0104
20120—051
20130—3163
20140—257
20150—065
20160—069
20170—155
20180—079
20190—025
20200—017
20210—049
20220—018
20230—042
20240—05
20250—02
20260—0—

What is it indicated for?

The Roche ONLINE Phenytoin assay contains an in vitro diagnostic reagent system indicated for the quantitative determination of phenytoin, an anti-convulsant drug, in human serum or plasma on automated clinical chemistry analyzers. Measurements obtained by the device are used in the diagnosis and treatment of phenytoin overdose and in monitoring levels of phenytoin to ensure appropriate therapy.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K030428: Roche Online TDM Phenytoin.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K030428

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026